Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.55 |
| ▸ | FNTB | P49356 | 3/20 | 0.55 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16430978 | 0.92 | LTA4H (0.58) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL17465627 | 0.92 | LTA4H (0.61) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL16430977 | 0.92 | LTA4H (0.58) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL31312636 | 0.92 | FNTA (0.60) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL29769731 | 0.91 | LTA4H (0.60) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL10435396 | 0.91 | FNTA (0.60) | FNTAFNTBPGGT1B | |
| SCHEMBL10435395 | 0.91 | FNTA (0.60) | FNTAFNTBPGGT1B | |
| SCHEMBL27983689 | 0.90 | LTA4H (0.64) | LTA4HMME | |
| SCHEMBL30917374 | 0.90 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4H | |
| SCHEMBL30051374 | 0.89 | FNTA (0.61) | FNTAFNTBPGGT1BLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442834-B2 | Deprotection method | AJINOMOTO CO., INC. (JP) | 2019-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10442834-B2 | Deprotection method | CBR1, AOX1, AOC2 | FNTA 2685/4885FNTB 3018/4885PGGT1B 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.